EUVIMEDEUVIMED entdecken
Leserbrief

ChatGPT's Response to the Diabetes Knowledge Questionnaire: Implications for Diabetes Education

Afif Nakhleh, Sivan Spitzer, Naim Shehadeh

Diabetes Technology & Therapeutics · 2023-08 · 25 (8) · 571-573

DOI: 10.1089/dia.2023.0134 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Diabetes Technology & Therapeutics, online erschienen am 31.07.2023. Verfasst von Afif Nakhleh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes and Endocrinology Clinic, Maccabi Healthcare Services, Haifa, Israel. Hauptthemen laut MEDLINE: Diabetes Mellitus. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes MellitusHumans

Autor:innen und Institutionen

  • Diabetes and Endocrinology Clinic, Maccabi Healthcare Services, Haifa, Israel.
  • Institute of Endocrinology, Diabetes and Metabolism, Rambam Health Care Campus, Haifa, Israel.
  • The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Zitieren

APA

Nakhleh, A., Spitzer, S., & Shehadeh, N. (2023). ChatGPT's Response to the Diabetes Knowledge Questionnaire: Implications for Diabetes Education. Diabetes Technology & Therapeutics, 25(8), 571-573. https://doi.org/10.1089/dia.2023.0134

Vancouver

Nakhleh A, Spitzer S, Shehadeh N. ChatGPT's Response to the Diabetes Knowledge Questionnaire: Implications for Diabetes Education. Diabetes Technology & Therapeutics. 2023;25(8):571-573. doi:10.1089/dia.2023.0134

BibTeX
@article{Nakhleh2023,
  author = {Nakhleh, Afif and Spitzer, Sivan and Shehadeh, Naim},
  title = {ChatGPT's Response to the Diabetes Knowledge Questionnaire: Implications for Diabetes Education},
  journal = {Diabetes Technology & Therapeutics},
  year = {2023},
  volume = {25},
  number = {8},
  pages = {571--573},
  doi = {10.1089/dia.2023.0134}
}
Kostenlos starten →